The Annals the journal of Pharmacy Technology
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 24 April 2007, www.theannals.com, DOI 10.1345/aph.1H129b.
 The Annals of Pharmacotherapy: Vol. 41, No. 5, pp. 902-903. DOI 10.1345/aph.1H129b
© 2007 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Costa, S.
Right arrow Articles by Silveira, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Costa, S.
Right arrow Articles by Silveira, J.

Authors' Reply

Suzete Costa, Pharmacist MPH

Department Manager, Department of Pharmacy-based Disease Management Programs, National Association of Pharmacies (ANF), Rue Marechal Saldanha, 1, 1249-069 Lisboa, Portugal, fax 351213400779, Suzete.Costa{at}anf.pt

Cristina Santos, Pharmacist

Program Supervisor. Department of Pharmacy-based Disease Management Programs, National Association of Pharmacies (ANF)

João Silveira, Pharmacist

Vice-President, National Association of Pharmacies (ANF)

Published Online, April 24, 2007. www.theannals.com, DOI 10.1345/aph.1H129b

In April 2005, with the sole purpose of conducting a rigorous investigation of community pharmacy research in Portugal, we contacted the Head of Department/Responsible Professor of Social Pharmacy in both universities (Lisbon and Coimbra). We requested detailed information from them about the most relevant pharmacy practice research projects and community pharmacy MSc/PhD dissertations published, concluded, or in progress in their institutions. This information was requested by email on April 18, 2005, and specified the purpose of the information required, identifying the nature of the article to be written and its authors, as well as the journal. A few days later, we received written replies from both universities. Thus, all of the information concerning research done by those universities given in our article was based solely on the information provided by the direct sources. It should be kept in mind that some relevant research in community pharmacy in Portugal undertaken by universities was probably not yet published or had not been made publicly available.

The first Portuguese research center targeted to community pharmacy was founded in 1994 in ANF. Although both universities have several community pharmacy research projects in progress, most have been developed since 2001.

According to the written information that we received from the University of Lisbon, as of April 2005, there were 2 completed community pharmacy MSc dissertations by Garção and Costa (instead of 8, as stated by Cavaco and Cabrita), 1 community pharmacy MSc dissertation in progress from Pereira (instead of 10), 1 PhD dissertation in progress from Martins, 1 article published1 (instead of 5), and 2 oral communications in the community pharmacy area (1 of them related to the MSc thesis in progress).

We would like to clarify that the protocol signed between ANF and the University of Lisbon mentioned by Cavaco and Cabrita refers to mutual cooperation in the area of pharmaceutical care with an emphasis on training, rather than on research.

Finally, as part of the global objective of this series, which is to provide an overview of community services worldwide, our purpose was to describe the status and outline the trends of community pharmacy services in Portugal. Research in community pharmacy represented a secondary aspect for the purpose of this article.

Footnotes

Letters are subject to review prior to acceptance. They should address areas related to pharmacy practice, research, or education, or articles recently published. Corrections of previously published material also are accepted. Letters are limited to no more than five authors. In cases where adverse drug effects are described, the Naranjo ADR probability scale should be used to determine the likelihood that the adverse effect was drug-related (Clin Pharmacol Ther 1981;30:239-45). Text: limit 500 words. References: limit 5. Art: limit 1 table or figure.

References

  1. Garção JA, Cabrita J. Evaluation of pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc 2002;42:858-64.[CrossRef]




This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Costa, S.
Right arrow Articles by Silveira, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Costa, S.
Right arrow Articles by Silveira, J.

homecopy help contact us subscription past issues search current issue